Polymorphisms of the IL-1 gene complex in coal miners with silicosis.

BACKGROUND Silicosis is characterized by fibrosing nodular lesions that eventually develop into progressive pulmonary fibrosis. Pro-inflammatory cytokines, such as interleukin-1 (IL-1), play a key role in the development of silicosis by regulating mediators which are responsible for lung injury, inflammation, and potentially fibrosis. To study whether functional single nucleotide polymorphisms (SNPs) located in the regulatory elements of genes coding for the IL-1alpha, IL-1beta, and IL-1 receptor antagonist (RA) cytokines are associated with silicosis, we examined 318 Caucasian cases confirmed histopathologically with pulmonary silicosis and 163 controls without any apparent inflammation or other pulmonary disease. METHODS Genotyping was carried out by polymerase chain reaction-restriction fragment length polymorphism technique. RESULTS The proportion of the IL-1RA (+ 2018) allele 2 genotype was increased in miners with silicosis (0.27) compared to controls (0.16). The odds of being a case were 2.15 (CI = 1.4-3.3) times higher for subjects with at least one copy of allele 2. No statistically significant differences in the allelic frequencies or genotype distributions for IL-1alpha (+ 4845) or IL-1beta (+ 3953) were found between the control and disease groups. CONCLUSIONS This is the first report showing an association between the IL-1RA (+ 2018) polymorphism and silicosis, and suggests that this polymorphism may confer increased risk for the development of the disease.

[1]  D. Hosmer,et al.  Applied Logistic Regression , 1991 .

[2]  D. Hemenway,et al.  Persistent overexpression of interleukin-1beta and tumor necrosis factor-alpha in murine silicosis. , 1998, Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer.

[3]  P. Miossec,et al.  Possible genetic association between interleukin-1alpha gene polymorphism and the severity of chronic polyarthritis. , 1999, European cytokine network.

[4]  Bernard R. Rosner,et al.  Fundamentals of Biostatistics. , 1992 .

[5]  A. R. Gibbs.  Diseases due to silica. , 1988 .

[6]  V. Pravica,et al.  Genotyping for polymorphisms in interferon-γ, interleukin-10, transforming growth factor-β1 and tumour necrosis factor-α genes: a technical report , 1998 .

[7]  I. Gery,et al.  Silica-stimulated monocytes release fibroblast proliferation factors identical to interleukin 1. A potential role for interleukin 1 in the pathogenesis of silicosis. , 1984, The Journal of clinical investigation.

[8]  G. M. Ridder,et al.  Pulmonary response to silica or titanium dioxide: inflammatory cells, alveolar macrophage-derived cytokines, and histopathology. , 1990, American journal of respiratory cell and molecular biology.

[9]  A. Blakemore,et al.  Severity of alopecia areata is associated with a polymorphism in the interleukin-1 receptor antagonist gene. , 1994, The Journal of investigative dermatology.

[10]  M. Cork,et al.  Genetic control of cytokines. Cytokine gene polymorphisms in alopecia areata. , 1996, Dermatologic clinics.

[11]  C. Fiocchi,et al.  Mucosal imbalance of IL-1 and IL-1 receptor antagonist in inflammatory bowel disease. A novel mechanism of chronic intestinal inflammation. , 1995, Journal of immunology.

[12]  G. Duff,et al.  The interleukin-1 genotype as a severity factor in adult periodontal disease. , 1997, Journal of clinical periodontology.

[13]  S. Mizel,et al.  Interleukin 1, a potential regulator of fibroblast proliferation. , 1982, Journal of immunology.

[14]  I. Lamster,et al.  The Influence of Interleukin Gene Polymorphism on Expression of Interleukin-1β and Tumor Necrosis Factor-α in Periodontal Tissue and Gingival Crevicular Fluid. , 1999, Journal of periodontology.

[15]  F. Pociot,et al.  A Taql polymorphism in the human interleukin‐1β (IL‐1β) gene correlates with IL‐1β secretion in vitro , 1992 .

[16]  S. Jimenez,et al.  Polymorphisms in the IL‐1 receptor antagonist gene VNTR are possible risk factors for juvenile idiopathic inflammatory myopathies , 2000, Clinical and experimental immunology.

[17]  P. Roux‐Lombard.  The interleukin-1 family. , 1999, European cytokine network.

[18]  D. Grennan,et al.  Cytokine production by normal human monocytes: inter‐subject variation and relationship to an IL‐1 receptor antagonist (IL‐1Ra) gene polymorphism , 1995, Clinical and experimental immunology.

[19]  F. Pociot,et al.  Monokine Antagonism Is Reduced in Patients With IDDM , 1994, Diabetes.

[20]  R. Płoski,et al.  A genetic association between juvenile rheumatoid arthritis and a novel interleukin-1α polymorphism , 1995 .

[21]  J. Mansfield,et al.  Novel genetic association between ulcerative colitis and the anti-inflammatory cytokine interleukin-1 receptor antagonist. , 1994, Gastroenterology.

[22]  C. Gordon,et al.  Interleukin-1 receptor antagonist gene polymorphism as a disease severity factor in systemic lupus erythematosus. , 1994, Arthritis and rheumatism.